August 7, 2021 Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders
August 4, 2021 Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications
August 3, 2021 Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease within 5 Years
August 3, 2021 Prediction of Neurological Recovery After Cardiac Arrest Using Neurofilament Light Chain is Improved by a Proteomics-Based Multimarker Panel
August 3, 2021 Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies
August 2, 2021 Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study
July 29, 2021 N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease
July 29, 2021 Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson’s disease (MARK-PD)
July 27, 2021 Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD-ALS spectrum